Glimepiride Tablet
Product Images NDC 60760-845

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 60760-845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

845-90 (Glimepiride 60760 845 90)

845-90 (Glimepiride 60760 845 90)
Label for Glimepiride Tablets USP 4 mg, quantity 90 tablets. Manufactured by Indoco Remedies Limited, India, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. Includes NDC 60760-845-90, placeholder lot and expiration dates, and storage instructions to keep at controlled room temperature 15°-30°C (59°-86°F).*
FDA Label Image

Glime Str (Glimestr)

Glime Str (Glimestr)
Chemical structure of glimepiride, an oral tablet used as a human prescription drug. The structure depicts rings, bonds, and functional groups characteristic of glimepiride's molecular composition.*
FDA Label Image

Fpp (Fpp)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.